HIGHLIGHTS
- who: Z. S. Khankhel from the PrecisionHEOR, Boston, MA, USA have published the research: Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR), in the Journal: (JOURNAL)
- what: Three of these four studies reported zero deaths , one of which specifically sought to record death due to infection . The 23 studies included in the review provided mostly observational evidence (i.e. cohort and case-control studies, case reports, case series), though few interventional studies were included (i.e. RCTs and single-arm trials). While inconsistency in some of the findings of the review . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.